newsThe IL-17A and IL–17F inhibitor demonstrated positive efficacy and safety…
24 May 2024 | By Catherine Eckford (European Pharmaceutical Review)
The IL-17A and IL–17F inhibitor demonstrated positive efficacy and safety in adults with moderate-to-severe hidradenitis suppurativa, new data shows.